363 related articles for article (PubMed ID: 22419350)
21. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
Huang ZY; Huang Q; Zeng HJ; Ma J; Shen B; Zhou ZK; Pei FX
BMC Musculoskelet Disord; 2019 Sep; 20(1):402. PubMed ID: 31481049
[TBL] [Abstract][Full Text] [Related]
22. High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
Tammachote N; Raphiphan R; Kanitnate S
Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1729-1735. PubMed ID: 31359178
[TBL] [Abstract][Full Text] [Related]
23. Tranexamic acid is effective in lower doses with infusion in total knee arthroplasty.
Aytuluk HG; Yaka HO
Acta Orthop Traumatol Turc; 2019 Mar; 53(2):81-85. PubMed ID: 30638779
[TBL] [Abstract][Full Text] [Related]
24. Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.
Wang HY; Wang L; Luo ZY; Wang D; Tang X; Zhou ZK; Pei FX
BMC Musculoskelet Disord; 2019 Oct; 20(1):478. PubMed ID: 31653221
[TBL] [Abstract][Full Text] [Related]
25. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Roy SP; Tanki UF; Dutta A; Jain SK; Nagi ON
Knee Surg Sports Traumatol Arthrosc; 2012 Dec; 20(12):2494-501. PubMed ID: 22419263
[TBL] [Abstract][Full Text] [Related]
27. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
Shin YS; Yoon JR; Lee HN; Park SH; Lee DH
Knee Surg Sports Traumatol Arthrosc; 2017 Nov; 25(11):3585-3595. PubMed ID: 27417102
[TBL] [Abstract][Full Text] [Related]
28. What is the Ideal Route of Administration of Tranexamic Acid in TKA? A Randomized Controlled Trial.
Lee SY; Chong S; Balasubramanian D; Na YG; Kim TK
Clin Orthop Relat Res; 2017 Aug; 475(8):1987-1996. PubMed ID: 28283902
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effects of intravenous and intra-articular tranexamic acid on reducing hemoglobin loss in revision total knee arthroplasty: a prospective, randomized, controlled study.
Yuan X; Wang J; Wang Q; Zhang X
Transfusion; 2018 Apr; 58(4):982-988. PubMed ID: 29399799
[TBL] [Abstract][Full Text] [Related]
30. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.
Xiong H; Liu Y; Zeng Y; Wu Y; Shen B
BMC Musculoskelet Disord; 2018 Sep; 19(1):321. PubMed ID: 30193586
[TBL] [Abstract][Full Text] [Related]
31. Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24).
Magill P; Hill JC; Bryce L; Martin U; Dorman A; Hogg R; Campbell C; Gardner E; McFarland M; Bell J; Benson G; Beverland D
Bone Joint J; 2021 Oct; 103-B(10):1595-1603. PubMed ID: 34587808
[TBL] [Abstract][Full Text] [Related]
32. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
Dai WL; Zhou AG; Zhang H; Zhang J
J Knee Surg; 2018 Aug; 31(7):654-663. PubMed ID: 28895645
[TBL] [Abstract][Full Text] [Related]
33. Comparison of intravenous and intra-articular tranexamic acid in reducing blood loss in primary total knee replacement.
Lacko M; Cellar R; Schreierova D; Vasko G
Eklem Hastalik Cerrahisi; 2017 Aug; 28(2):64-71. PubMed ID: 28760121
[TBL] [Abstract][Full Text] [Related]
34. A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty.
Prakash J; Seon JK; Park YJ; Jin C; Song EK
J Orthop Surg (Hong Kong); 2017 Jan; 25(1):2309499017693529. PubMed ID: 28222649
[TBL] [Abstract][Full Text] [Related]
35. The optimal protocol to reduce blood loss and blood transfusion after unilateral total knee replacement: Low-dose IA-TXA plus 30-min drain clamping versus drainage clamping for the first 3 h without IA-TXA.
Park JH; Choi SW; Shin EH; Park MH; Kim MK
J Orthop Surg (Hong Kong); 2017; 25(3):2309499017731626. PubMed ID: 28950794
[TBL] [Abstract][Full Text] [Related]
36. [A PROSPECTIVE RANDOMIZED SELF-CONTROLLED STUDY ON EFFECT OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS IN TOTAL KNEE ARTHROPLASTY].
Huang Z; Zhang W; Li W; Bai G; Zhang C; Lin J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar; 29(3):280-3. PubMed ID: 26455190
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty.
Sun Q; Yu X; Wu J; Ge W; Cai M; Li S
J Arthroplasty; 2017 Jul; 32(7):2108-2112. PubMed ID: 27889307
[TBL] [Abstract][Full Text] [Related]
38. Tranexamic Acid Plus Low-dose Epinephrine Reduces Blood Loss in Total Knee Arthroplasty: A Systematic Review and Meta-analysis.
Wu YG; Zeng Y; Hu QS; Bao XC; Xiong HZ; Shen B
Orthop Surg; 2018 Nov; 10(4):287-295. PubMed ID: 30406972
[TBL] [Abstract][Full Text] [Related]
39. Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.
Wang D; Zhu H; Meng WK; Wang HY; Luo ZY; Pei FX; Li Q; Zhou ZK
BMC Musculoskelet Disord; 2018 Mar; 19(1):85. PubMed ID: 29544472
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial.
Lei Y; Xie J; Xu B; Xie X; Huang Q; Pei F
Int Orthop; 2017 Oct; 41(10):2053-2059. PubMed ID: 28567578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
